4//SEC Filing
Bucher James B 4
Accession 0001664928-26-000003
CIK 0001725160other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 8:35 PM ET
Size
5.6 KB
Accession
0001664928-26-000003
Insider Transaction Report
Form 4
Bucher James B
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2026-01-08+100,000→ 100,000 totalExercise: $2.84Exp: 2036-01-07→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.
Documents
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
Related Parties
1- filerCIK 0001664928
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 8:35 PM ET
- Size
- 5.6 KB